Loading...

We've got a brand new version of Simply Wall St! Try it out

LifeVantage

Nasdaq:LFVN
Snowflake Description

Flawless balance sheet with proven track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
LFVN
Nasdaq
$199M
Market Cap
  1. Home
  2. US
  3. Household
Company description

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and personal care products. The last earnings update was 14 days ago. More info.


Add to Portfolio Compare Print
LFVN Share Price and Events
7 Day Returns
-4%
NasdaqCM:LFVN
2.2%
US Personal Products
0.3%
US Market
1 Year Returns
18.2%
NasdaqCM:LFVN
20.5%
US Personal Products
12.5%
US Market
LFVN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
LifeVantage (LFVN) -4% -0.1% 14.1% 18.2% 79.6% 55.3%
US Personal Products 2.2% -1.1% 5.5% 20.5% 54.3% 59.2%
US Market 0.3% 4.1% 5.6% 12.5% 39.4% 44.7%
1 Year Return vs Industry and Market
  • LFVN underperformed the Personal Products industry which returned 20.5% over the past year.
  • LFVN outperformed the Market in United States of America which returned 12.5% over the past year.
Price Volatility
LFVN
Industry
5yr Volatility vs Market

LFVN Value

 Is LifeVantage undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of LifeVantage to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for LifeVantage.

NasdaqCM:LFVN Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 7.5%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqCM:LFVN
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Personal Products Unlevered Beta Simply Wall St/ S&P Global 0.68
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.68 (1 + (1- 21%) (2.1%))
0.793
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.8 * 5.96%)
7.5%

Discounted Cash Flow Calculation for NasdaqCM:LFVN using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for LifeVantage is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

NasdaqCM:LFVN DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.5%)
2020 8.01 Est @ -8.66% 7.46
2021 7.59 Est @ -5.24% 6.57
2022 7.38 Est @ -2.85% 5.94
2023 7.29 Est @ -1.18% 5.46
2024 7.29 Est @ -0.01% 5.08
2025 7.35 Est @ 0.82% 4.76
2026 7.45 Est @ 1.39% 4.49
2027 7.59 Est @ 1.79% 4.25
2028 7.74 Est @ 2.07% 4.04
2029 7.92 Est @ 2.27% 3.84
Present value of next 10 years cash flows $51.00
NasdaqCM:LFVN DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $7.92 × (1 + 2.73%) ÷ (7.5% – 2.73%)
$170.62
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $170.62 ÷ (1 + 7.5%)10
$82.80
NasdaqCM:LFVN Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $51.00 + $82.80
$133.80
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $133.80 / 13.98
$9.57
NasdaqCM:LFVN Discount to Share Price
Calculation Result
Value per share (USD) From above. $9.57
Current discount Discount to share price of $14.24
= -1 x ($14.24 - $9.57) / $9.57
-48.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of LifeVantage is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for LifeVantage's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are LifeVantage's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:LFVN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in USD $0.59
NasdaqCM:LFVN Share Price ** NasdaqCM (2019-11-12) in USD $14.24
United States of America Personal Products Industry PE Ratio Median Figure of 21 Publicly-Listed Personal Products Companies 17.08x
United States of America Market PE Ratio Median Figure of 2,922 Publicly-Listed Companies 18.25x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of LifeVantage.

NasdaqCM:LFVN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:LFVN Share Price ÷ EPS (both in USD)

= 14.24 ÷ 0.59

24.18x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LifeVantage is overvalued based on earnings compared to the US Personal Products industry average.
  • LifeVantage is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does LifeVantage's expected growth come at a high price?
Raw Data
NasdaqCM:LFVN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 24.18x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
3%per year
United States of America Personal Products Industry PEG Ratio Median Figure of 6 Publicly-Listed Personal Products Companies 2.56x
United States of America Market PEG Ratio Median Figure of 2,023 Publicly-Listed Companies 1.46x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for LifeVantage, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on LifeVantage's assets?
Raw Data
NasdaqCM:LFVN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in USD $2.11
NasdaqCM:LFVN Share Price * NasdaqCM (2019-11-12) in USD $14.24
United States of America Personal Products Industry PB Ratio Median Figure of 43 Publicly-Listed Personal Products Companies 2.65x
United States of America Market PB Ratio Median Figure of 5,066 Publicly-Listed Companies 1.74x
NasdaqCM:LFVN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:LFVN Share Price ÷ Book Value per Share (both in USD)

= 14.24 ÷ 2.11

6.75x

* Primary Listing of LifeVantage.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LifeVantage is overvalued based on assets compared to the US Personal Products industry average.
X
Value checks
We assess LifeVantage's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Personal Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Personal Products industry average (and greater than 0)? (1 check)
  5. LifeVantage has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

LFVN Future Performance

 How is LifeVantage expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover LifeVantage, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is LifeVantage expected to grow at an attractive rate?
  • LifeVantage's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • LifeVantage's earnings growth is positive but not above the United States of America market average.
  • Unable to compare LifeVantage's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:LFVN Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqCM:LFVN Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 3%
United States of America Personal Products Industry Earnings Growth Rate Market Cap Weighted Average 17.7%
United States of America Personal Products Industry Revenue Growth Rate Market Cap Weighted Average 6.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.2%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:LFVN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:LFVN Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-09-30 227 12 8
2019-06-30 226 18 7
2019-03-31 224 16 7
2018-12-31 218 16 6
2018-09-30 210 13 6
2018-06-30 203 13 6
2018-03-31 200 10 3
2017-12-31 194 6 1
2017-09-30 194 6 1
2017-06-30 199 7 2
2017-03-31 202 4 4
2016-12-31 213 3 5

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • LifeVantage's earnings are expected to grow by 3% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if LifeVantage is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:LFVN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from LifeVantage Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:LFVN Past Financials Data
Date (Data in USD Millions) EPS *
2019-09-30 0.59
2019-06-30 0.53
2019-03-31 0.46
2018-12-31 0.45
2018-09-30 0.42
2018-06-30 0.41
2018-03-31 0.20
2017-12-31 0.09
2017-09-30 0.09
2017-06-30 0.12
2017-03-31 0.29
2016-12-31 0.36

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if LifeVantage will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess LifeVantage's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
LifeVantage has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

LFVN Past Performance

  How has LifeVantage performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare LifeVantage's growth in the last year to its industry (Personal Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • LifeVantage's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
  • LifeVantage's 1-year earnings growth exceeds its 5-year average (41.4% vs -10%)
  • LifeVantage's earnings growth has exceeded the US Personal Products industry average in the past year (41.4% vs 19.9%).
Earnings and Revenue History
LifeVantage's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from LifeVantage Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:LFVN Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 226.58 8.28 177.55
2019-06-30 225.96 7.43 178.17
2019-03-31 223.82 6.51 179.04
2018-12-31 218.37 6.37 173.88
2018-09-30 209.69 5.86 164.13
2018-06-30 203.20 5.76 158.03
2018-03-31 199.81 2.85 156.58
2017-12-31 194.26 1.28 153.79
2017-09-30 193.72 1.25 156.50
2017-06-30 199.49 1.61 161.58
2017-03-31 201.88 3.96 160.93
2016-12-31 213.03 4.90 167.19
2016-09-30 216.08 6.22 167.56
2016-06-30 206.54 6.11 159.19
2016-03-31 198.81 3.90 156.09
2015-12-31 187.80 3.47 149.39
2015-09-30 184.06 3.34 145.94
2015-06-30 190.34 7.13 148.43
2015-03-31 201.07 9.11 154.29
2014-12-31 210.98 11.03 160.31
2014-09-30 214.27 12.84 161.07
2014-06-30 213.97 11.38 161.33
2014-03-31 209.44 8.85 166.28 -2.11
2013-12-31 204.75 9.77 161.81 -1.26
2013-09-30 206.65 6.70 160.52 -0.51
2013-06-30 208.18 7.61 159.47
2013-03-31 201.27 12.62 142.41 2.54
2012-12-31 187.11 4.36 129.04 2.07

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • LifeVantage has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • LifeVantage used its assets more efficiently than the US Personal Products industry average last year based on Return on Assets.
  • LifeVantage's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess LifeVantage's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Personal Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
LifeVantage has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

LFVN Health

 How is LifeVantage's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up LifeVantage's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • LifeVantage is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • LifeVantage's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of LifeVantage's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 43.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from LifeVantage Company Filings, last reported 1 month ago.

NasdaqCM:LFVN Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 29.62 0.97 13.01
2019-06-30 27.20 1.45 18.82
2019-03-31 24.75 1.94 15.91
2018-12-31 21.02 4.43 18.99
2018-09-30 23.53 4.92 17.12
2018-06-30 21.95 5.41 16.65
2018-03-31 19.30 5.97 13.95
2017-12-31 16.51 6.46 12.79
2017-09-30 15.77 6.95 12.29
2017-06-30 14.53 7.44 11.46
2017-03-31 13.90 7.93 9.20
2016-12-31 14.51 8.42 11.73
2016-09-30 14.08 8.92 10.23
2016-06-30 10.65 9.41 7.88
2016-03-31 8.84 9.90 8.49
2015-12-31 7.01 13.27 15.82
2015-09-30 4.58 16.74 13.69
2015-06-30 3.33 19.67 13.91
2015-03-31 2.83 26.40 15.35
2014-12-31 4.55 27.52 18.65
2014-09-30 7.20 28.65 22.14
2014-06-30 3.99 29.77 20.39
2014-03-31 2.73 44.73 35.68
2013-12-31 -0.55 45.86 34.45
2013-09-30 35.08 0.00 27.96
2013-06-30 33.95 0.00 26.30
2013-03-31 34.86 0.00 27.24
2012-12-31 35.03 0.00 28.47
  • LifeVantage's level of debt (3.3%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (399.5% vs 3.3% today).
  • Debt is well covered by operating cash flow (1234.6%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 42.4x coverage).
X
Financial health checks
We assess LifeVantage's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. LifeVantage has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

LFVN Dividends

 What is LifeVantage's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from LifeVantage dividends.
If you bought $2,000 of LifeVantage shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate LifeVantage's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate LifeVantage's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:LFVN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Personal Products Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 1.5%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1948 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as LifeVantage has not reported any payouts.
  • Unable to verify if LifeVantage's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of LifeVantage's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as LifeVantage has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess LifeVantage's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can LifeVantage afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. LifeVantage has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

LFVN Management

 What is the CEO of LifeVantage's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Darren Jensen
COMPENSATION $5,025,497
AGE 50
TENURE AS CEO 4.5 years
CEO Bio

Mr. Darren Jay Jensen has been the Chief Executive Officer and President of Lifevantage Corp. since May 18, 2015 and has been its Director since January 8, 2016. From June 2014 to May 2015, Mr. Jensen served as the President-Americas and from September 2012 to June 2014 as the Chief Sales Officer at Jeunesse Global, a privately held direct selling anti-aging and skin care company. He served as Chief Sales Officer at Ampegy LLC from August 23, 2011 to June 2012. He served as Executive Vice President, General Manager of EMEA, General Manager of Asia & Pacific Rim and Chief Operating Officer at Agel Enterprises, LLC. He was also a Co-Founder of the Agel Cares Foundation. Mr. Jensen's experience includes working for companies like Amway and NuSkin and co-founding Synergy Worldwide. In addition to operations, he has held vital management positions in international marketing and product development. He has more than 25 years of sales and business development experience in network marketing with him to Ampegy. From 2003 to 2005, Mr. Jensen was the Director of International Business Development at USANA Inc. He served as a Brand Manager at Amway Global from 1995 to 1997. Mr. Jensen began his direct selling career at Nu Skin Enterprises in Provo, where he served as an International Marketing Specialist from 1990 to 1995. He served in various management positions in international business, operations and product development and has advanced through successive leadership roles. He is an accomplished business leader earning Utah Business magazine's 2009 Top Forty Under 40 award and he was a Stevie Awards finalist for Sales & Customer Service in the Worldwide Vice President of Sales category. Mr. Jensen holds a BA in International Relations from Brigham Young University.

CEO Compensation
  • Darren's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Darren's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the LifeVantage management team in years:

3.7
Average Tenure
51
Average Age
  • The tenure for the LifeVantage management team is about average.
Management Team

Darren Jensen

TITLE
President
COMPENSATION
$5M
AGE
50
TENURE
4.5 yrs

Steven Fife

TITLE
Chief Financial Officer
COMPENSATION
$2M
AGE
58
TENURE
2.7 yrs

Kevin McMurray

TITLE
General Counsel
COMPENSATION
$1M
AGE
57
TENURE
2.2 yrs

Justin Rose

TITLE
Chief Sales Officer
COMPENSATION
$1M
AGE
51
TENURE
4.3 yrs

Ryan Goodwin

TITLE
Chief Marketing Officer
COMPENSATION
$1M
AGE
42
TENURE
4.1 yrs

Chuck Wach

TITLE
Chief Operating Officer
COMPENSATION
$572K
AGE
57
TENURE
2.7 yrs

Eric Marchant

TITLE
Vice President of Compliance

Chris Taylor

TITLE
Director of Communications

Michelle Oborn-Virchow

TITLE
Senior Vice President of Human Resources
COMPENSATION
$627K
AGE
39
TENURE
4 yrs

Dave Fleming

TITLE
Senior Vice President of Global Field Development - Americas & Europe
TENURE
3.3 yrs
Board of Directors Tenure

Average tenure and age of the LifeVantage board of directors in years:

2.8
Average Tenure
59
Average Age
  • The average tenure for the LifeVantage board of directors is less than 3 years, this suggests a new board.
Board of Directors

Garry Mauro

TITLE
Independent Chairman
COMPENSATION
$224K
AGE
71
TENURE
6 yrs

Darren Jensen

TITLE
President
COMPENSATION
$5M
AGE
50
TENURE
3.8 yrs

Michael Beindorff

TITLE
Independent Director
COMPENSATION
$218K
AGE
67
TENURE
7.8 yrs

Ray Greer

TITLE
Independent Director
COMPENSATION
$212K
AGE
56
TENURE
2.8 yrs

Darwin Lewis

TITLE
Independent Director
COMPENSATION
$218K
AGE
60
TENURE
2.8 yrs

Vinayak Hegde

TITLE
Independent Director
COMPENSATION
$212K
AGE
49
TENURE
2.8 yrs

Erin Brockovich

TITLE
Independent Director
COMPENSATION
$51K
AGE
59
TENURE
0.5 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
30. Nov 18 Buy Raymond Greer Individual 30. Nov 18 30. Nov 18 1,500 $13.22 $19,830
27. Nov 18 Buy Garry Mauro Individual 26. Nov 18 26. Nov 18 1,150 $11.94 $13,731
X
Management checks
We assess LifeVantage's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. LifeVantage has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

LFVN News

Simply Wall St News

LifeVantage Corporation (NASDAQ:LFVN): The Best Of Both Worlds

LFVN's strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. … Take a look at our free research report of analyst consensus for LFVN’s outlook. … The intrinsic value infographic in our free research report helps visualize whether LFVN is currently mispriced by the market.

Simply Wall St -

Did LifeVantage's (NASDAQ:LFVN) Share Price Deserve to Gain 21%?

Unfortunately for shareholders, while the LifeVantage Corporation (NASDAQ:LFVN) share price is up 21% in the last five years, that's less than the market return. … One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. … LifeVantage's earnings per share are down 4.0% per year, despite strong share price performance over five years.

Simply Wall St -

What Does LifeVantage Corporation's (NASDAQ:LFVN) P/E Ratio Tell You?

The formula for P/E is: Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS) Or for LifeVantage: P/E of 24.12 = $11.2 ÷ $0.46 (Based on the year to March 2019.) Is A High Price-to-Earnings Ratio Good? … A higher P/E ratio means that investors are paying a higher price for each $1 of company earnings. … All else being equal, it's better to pay a low price -- but as Warren Buffett said, 'It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.' How Does LifeVantage's P/E Ratio Compare To Its Peers?

Simply Wall St -

Is LifeVantage (NASDAQ:LFVN) Using Too Much Debt?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. … NasdaqCM:LFVN Historical Debt, July 4th 2019 A Look At LifeVantage's Liabilities Zooming in on the latest balance sheet data, we can see that LifeVantage had liabilities of US$27.5m due within 12 months and liabilities of US$1.88m due beyond that. … While LifeVantage has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance.

Simply Wall St -

If You Like EPS Growth Then Check Out LifeVantage (NASDAQ:LFVN) Before It's Too Late

In the last twelve months LifeVantage insiders spent US$34k on stock; good news for shareholders. … Along with the insider buying, another encouraging sign for LifeVantage is that insiders, as a group, have a considerable shareholding. … The good news is that LifeVantage is not the only growth stock with insider buying.

Simply Wall St -

LifeVantage Corporation (NASDAQ:LFVN) Is Employing Capital Very Effectively

The formula for calculating the return on capital employed is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for LifeVantage: 0.32 = US$8.4m ÷ (US$54m - US$27m) (Based on the trailing twelve months to March 2019.) So, LifeVantage has an ROCE of 32%. … Due to the way ROCE is calculated, a high level of current liabilities makes a company look as though it has less capital employed, and thus can (sometimes unfairly) boost the ROCE. … LifeVantage boasts an attractive ROCE, even after considering the boost from high current liabilities.

Simply Wall St -

Could The LifeVantage Corporation (NASDAQ:LFVN) Ownership Structure Tell Us Something Useful?

Taking a look at our data on the ownership groups (below), it's seems that institutional investors have bought into the company. … View our latest analysis for LifeVantage NasdaqCM:LFVN Ownership Summary, May 16th 2019 What Does The Institutional Ownership Tell Us About LifeVantage? … Insider Ownership Of LifeVantage The definition of company insiders can be subjective, and does vary between jurisdictions.

Simply Wall St -

Does LifeVantage Corporation's (NASDAQ:LFVN) CEO Pay Matter?

Darren Jensen became the CEO of LifeVantage Corporation (NASDAQ:LFVN) in 2015. … First, this article will compare CEO compensation with compensation at similar sized companies. … How Does Darren Jensen's Compensation Compare With Similar Sized Companies?

Simply Wall St -

Can You Imagine How Chuffed LifeVantage's (NASDAQ:LFVN) Shareholders Feel About Its 196% Share Price Gain?

LifeVantage Corporation (NASDAQ:LFVN) shareholders have seen the share price descend 21% over the month. … Like an eagle, the share price soared 196% in that time. … One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

Simply Wall St -

Why LifeVantage Corporation's (NASDAQ:LFVN) High P/E Ratio Isn't Necessarily A Bad Thing

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). … We'll show how you can use LifeVantage Corporation's (NASDAQ:LFVN) P/E ratio to inform your assessment of the investment opportunity. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

LFVN Company Info

Description

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and personal care products. The company offers Protandim, a line of scientifically-validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, and hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. The company sells its products through its Website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, and China. The company was formerly known as Lifeline Therapeutics, Inc. and changed its name to LifeVantage Corporation in November 2006. LifeVantage Corporation is headquartered in Sandy, Utah.

Details
Name: LifeVantage Corporation
LFVN
Exchange: NasdaqCM
Founded:
$199,064,576
13,979,254
Website: http://www.lifevantage.com
Address: LifeVantage Corporation
9785 South Monroe Street,
Suite 400,
Sandy,
Utah, 84070,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM LFVN Common Stock Nasdaq Capital Market US USD 06. Oct 2004
DB L2T1 Common Stock Deutsche Boerse AG DE EUR 06. Oct 2004
Number of employees
Current staff
Staff numbers
227
LifeVantage employees.
Industry
Personal Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/11/13 00:11
End of day share price update: 2019/11/12 00:00
Last earnings filing: 2019/10/30
Last earnings reported: 2019/09/30
Last annual earnings reported: 2019/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.